Modulating Novel Mitochondrial Targets to Treat Mitochondrial Disease, Diseases of Aging & Metabolism
Time: 3:25 pm
day: CONFERENCE DAY ONE
Details:
- Unveiling small molecule activators of the mitochondrial DNA polymerase, POLG, to treat mitochondrial DNA depletion syndromes and beyond
- Exploring inhibitors of the mitochondrial RNA polymerase, POLRMT, to treat obesity and metabolic disorders
- Leveraging a unique mitochondrial biology discovery platform to develop a pipeline of novel therapeutics
